Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)
US pharma giant Pfizer (NYSE: PFE) has struck a commercialization deal with Chinas Sciwind Biosciences for the GLP-1 drug Xianyida (ecnoglutide), gaining exclusive rights in mainland China in a pact worth up to $495 million
Prioritize Health, Not Weight Loss We discourage arbitrary weight goals, and we celebrate health improvements, Saunders says
For example, the lifelong paradox: one counterintuitive finding is that lifelong treatment provides a much stronger fiscal case than a defined period of use, as some guidelines require, because the health care savings compound
US$ 25.36
US$ 22.85
US$ 27.88
